Financial institutions that bank hemp-related businesses should be aware of significant federal changes that may affect whether certain products continue to qualify as legal hemp. Congress revised the federal definition of hemp in November 2025, narrowing the scope of products that may be lawfully marketed as hemp and creating new compliance considerations for banks that serve the industry.

The revised definition replaces the previous delta-9 THC measurement with a total THC standard that includes THCA, delta-9 THC, and other cannabinoids with similar intoxicating effects. In addition, final-form hemp-derived cannabinoid products will be limited to 0.4 milligrams of total THC per container.

Although the original implementation date was November 12, 2026, certain provisions were delayed until December 11, 2026. As currently structured:

Effective November 12, 2026

  • Hemp-derived cannabinoid products containing synthetic or chemically produced cannabinoids are prohibited.

Effective December 11, 2026

  • The federal hemp definition transitions to a 0.3% total THC standard.
  • Final-form hemp-derived cannabinoid products become subject to the 0.4 mg total THC per container limitation.

While these changes do not amend the Bank Secrecy Act (BSA) or impose new anti-money laundering (AML) requirements, they may increase the legal, regulatory, and reputational risk associated with certain hemp customers and require institutions to revisit their risk management practices.

Why These Changes Matter to Financial Institutions

The regulatory changes do not create a new BSA requirement. However, they may alter the legal status of products currently sold by hemp-related businesses.

As a result, institutions may find that some customers previously categorized as lower-risk hemp businesses now present elevated legal, regulatory, compliance, or reputational risk. Businesses involved in delta-8 products, THCA flower, hemp-derived beverages, cannabinoid processing, and chemically modified cannabinoid products may be particularly impacted.

For institutions that have developed hemp banking programs over the past several years, these changes may necessitate a reassessment of customer relationships and associated controls.

What Banks Should Be Doing Now

Financial institutions that serve hemp-related businesses should consider:

  • Identifying customers engaged in hemp cultivation, processing, distribution, manufacturing, or retail sales.
  • Determining whether any customers sell products containing delta-8 THC, THCA, hemp-derived beverages, or chemically modified cannabinoids.
  • Reviewing customer due diligence files to ensure licensing information, product information, and Certificates of Analysis (COAs) are current.
  • Assessing whether existing customer risk ratings remain appropriate.
  • Evaluating whether transaction monitoring controls adequately identify activity associated with products that may no longer meet the federal definition of hemp.
  • Monitoring regulatory developments and customer preparedness efforts leading up to the December 11, 2026 implementation date.

Customer Due Diligence Considerations

As part of ongoing customer due diligence (CDD), institutions may consider obtaining and reviewing:

  • Current product inventories
  • Certificates of Analysis (COAs)
  • State licensing and registration documentation
  • THC testing methodologies
  • Manufacturing and processing information
  • Legal opinions supporting product compliance for higher-risk businesses

Risk management teams should understand how individual customers generate revenue and whether those revenue streams may be impacted by the revised federal standards.

Customer Risk Rating Implications

Existing customer risk-rating methodologies may require adjustment to address the evolving regulatory environment.

Institutions should consider enhanced review procedures for businesses engaged in:

  • Delta-8 THC manufacturing
  • THCA flower cultivation or sales
  • Hemp-derived beverage production
  • Online cannabinoid sales
  • Chemical conversion or synthetic cannabinoid processing

Transaction Monitoring and Suspicious Activity Reporting

The federal hemp changes do not automatically trigger suspicious activity reporting requirements. However, institutions should evaluate whether transaction monitoring systems remain effective for identifying activity associated with potentially unlawful products.

Examples of activity that may warrant additional review include:

  • Continued sales of products that no longer meet the federal definition of hemp
  • Material changes in transaction volumes following implementation dates
  • Attempts to obscure the nature of customer activities
  • Significant cash activity inconsistent with historical trends
  • Transactions involving jurisdictions where products are prohibited

As with any potentially suspicious activity, institutions should evaluate the facts and circumstances of the relationship to determine whether SAR filing obligations exist.

Additional Risk Management Considerations

Following implementation of the revised federal standards, some businesses currently operating as hemp-related businesses may derive revenue from products that no longer qualify as federally lawful hemp products.

Financial institutions should determine whether affected customers continue to qualify as hemp-related businesses under federal law and whether additional monitoring, enhanced due diligence, or other risk management measures are warranted. Institutions should also evaluate whether any customer relationships exceed the institution’s established risk appetite.

Bottom Line

The revised federal hemp definition represents a significant regulatory development for hemp-related businesses and the financial institutions that serve them. Although the changes do not alter BSA requirements, they may substantially increase the compliance risk associated with certain customers and products.

Institutions should proactively review their hemp banking portfolios, update customer due diligence procedures, reassess risk ratings, and ensure transaction monitoring processes remain aligned with the evolving regulatory landscape. Taking these steps before the December 11, 2026, implementation date will help institutions identify emerging risks and demonstrate a sound, risk-based approach to hemp-related banking relationships.

Financial institutions should avoid assuming that a customer’s historical status as a hemp business guarantees ongoing compliance under the revised federal framework. A proactive review of affected relationships can help institutions manage risk, support informed SAR decision-making, and maintain alignment with BSA/AML expectations as the regulatory environment continues to evolve.

Source: Section 781 of the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026, as amended by H.R. 6500 (2026).

CCI suggests sharing this update with your institution’s BSA/AML/CFT Officer. If you have questions regarding this information, contact CCI’s Cannabis Banking Specialist at inquiries@completecompli.com.

We Have Something New to Share

Over the years, many of our clients have relied on us for guidance related to cannabis and hemp banking. As this area continues to evolve, we have created a dedicated LinkedIn presence focused exclusively on cannabis banking compliance.

Cannabis Compliance, Inc. will serve as our hub for:

  • Cannabis and hemp banking updates
  • BSA/AML guidance
  • Regulatory developments
  • Examination trends
  • Compliance resources
  • Industry insights for financial institutions

If cannabis or hemp banking is part of your institution’s current or future strategy, we’d love for you to follow along.

Follow Cannabis Compliance, Inc. on LinkedIn here.

We’ll continue sharing general compliance content through Complete Compliance, Inc., while using Cannabis Compliance, Inc. to provide focused updates on cannabis and hemp banking topics.